| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.77M | 30.41M | 21.85M | 8.82M | 10.82M | 9.03M |
| Gross Profit | 5.36M | 17.83M | 8.07M | 3.35M | 5.19M | 4.02M |
| EBITDA | -14.35M | -4.46M | -4.16M | -6.55M | 163.53K | 399.69K |
| Net Income | -10.81M | -1.48M | -4.19M | -6.68M | -338.16K | 150.96K |
Balance Sheet | ||||||
| Total Assets | 13.34M | 13.97M | 19.62M | 12.14M | 9.12M | 10.36M |
| Cash, Cash Equivalents and Short-Term Investments | 4.35M | 6.62M | 1.95M | 7.18M | 3.14M | 3.06M |
| Total Debt | 946.72K | 3.78M | 4.89M | 4.55M | 6.19M | 8.49M |
| Total Liabilities | 9.51M | 10.50M | 11.96M | 7.33M | 9.68M | 11.42M |
| Stockholders Equity | 5.19M | 4.65M | 5.17M | 4.81M | -558.95K | -1.41M |
Cash Flow | ||||||
| Free Cash Flow | -4.26M | -4.78M | -4.86M | -4.87M | 730.15K | 718.58K |
| Operating Cash Flow | -4.26M | -4.77M | -4.33M | -4.81M | 766.30K | 745.75K |
| Investing Cash Flow | 4.81M | 6.35M | -1.78M | -12.20K | -179.03K | -401.15K |
| Financing Cash Flow | 1.21M | -318.65K | 136.19K | 8.92M | -257.35K | 2.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | $8.70M | -0.65 | -5.71% | 41.26% | -51.26% | -319.52% | |
45 Neutral | $11.09M | -0.58 | -80.59% | ― | -27.47% | 83.06% | |
40 Underperform | $10.72M | -0.06 | -269.14% | ― | -73.83% | 98.11% |
On November 10, 2025, HeartCore Enterprises, Inc. announced it received an additional 180-day extension from the Nasdaq Listing Qualifications Department to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The extension, which lasts until May 1, 2026, has no immediate effect on the company’s stock listing status, but failure to comply could lead to delisting. HeartCore is considering actions such as a reverse stock split to regain compliance, though no decisions have been made yet.
On October 31, 2025, HeartCore Enterprises, Inc. announced the sale of its subsidiary, HeartCore Japan, to Volaris Group for approximately ¥1.8 billion yen, equivalent to about USD $12 million. This strategic divestiture allows HeartCore to focus on its Go IPO consulting business, as the company adapts to the evolving competitive landscape influenced by generative AI. The sale is part of HeartCore’s broader strategy to exit its software business activities and concentrate on its highly profitable financial consulting services. The company also plans to distribute a portion of the sale proceeds to shareholders and is exploring options to divest its interest in Sigmaways, Inc. HeartCore anticipates that these moves will enable it to drive sustainable, long-term value for its shareholders.
On October 29, 2025, HeartCore Enterprises, Inc. clarified that a previously announced one-time payment to stockholders of $0.13 per share, initially described as a dividend, will be classified as a distribution for U.S. federal tax purposes. The record date for this distribution is November 10, 2025, and the payment date is expected to be November 17, 2025. This distribution represents approximately 16.8% of the company’s stock price as of October 27, 2025, potentially impacting stockholder returns and market perception.
On October 19, 2025, HeartCore Enterprises, Inc. declared a one-time dividend of $0.13 per share on its common stock, representing approximately 17.8% of the company’s stock price as of October 17, 2025. The dividend, deemed in the best interest of the company and its stockholders, will be payable on November 17, 2025, to stockholders of record as of November 10, 2025. This move reflects HeartCore’s strong financial profile and may lead to future quarterly dividends, subject to board approval.
On September 26, 2025, HeartCore Enterprises, Inc. conducted its virtual annual meeting of stockholders, where five directors were elected to the board for a one-year term. Additionally, the stockholders ratified the appointment of MaloneBailey, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.